Literature DB >> 22445518

Direct conversion of fibroblasts into stably expandable neural stem cells.

Marc Thier1, Philipp Wörsdörfer, Yenal B Lakes, Raphaela Gorris, Stefan Herms, Thoralf Opitz, Dominic Seiferling, Tamara Quandel, Per Hoffmann, Markus M Nöthen, Oliver Brüstle, Frank Edenhofer.   

Abstract

Recent advances have suggested that direct induction of neural stem cells (NSCs) could provide an alternative to derivation from somatic tissues or pluripotent cells. Here we show direct derivation of stably expandable NSCs from mouse fibroblasts through a curtailed version of reprogramming to pluripotency. By constitutively inducing Sox2, Klf4, and c-Myc while strictly limiting Oct4 activity to the initial phase of reprogramming, we generated neurosphere-like colonies that could be expanded for more than 50 passages and do not depend on sustained expression of the reprogramming factors. These induced neural stem cells (iNSCs) uniformly display morphological and molecular features of NSCs, such as the expression of Nestin, Pax6, and Olig2, and have a genome-wide transcriptional profile similar to that of brain-derived NSCs. Moreover, iNSCs can differentiate into neurons, astrocytes, and oligodendrocytes. Our results demonstrate that functional NSCs can be generated from somatic cells by factor-driven induction.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22445518     DOI: 10.1016/j.stem.2012.03.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  243 in total

Review 1.  Generation of pluripotent stem cells without the use of genetic material.

Authors:  Akon Higuchi; Qing-Dong Ling; S Suresh Kumar; Murugan A Munusamy; Abdullah A Alarfaj; Yung Chang; Shih-Hsuan Kao; Ke-Chen Lin; Han-Chow Wang; Akihiro Umezawa
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

2.  Induced neural stem cells: a new tool for studying neural development and neurological disorders.

Authors:  Guang-Hui Liu; Fei Yi; Keiichiro Suzuki; Jing Qu; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2012-05-01       Impact factor: 25.617

3.  Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor.

Authors:  Karen L Ring; Leslie M Tong; Maureen E Balestra; Robyn Javier; Yaisa Andrews-Zwilling; Gang Li; David Walker; William R Zhang; Anatol C Kreitzer; Yadong Huang
Journal:  Cell Stem Cell       Date:  2012-06-07       Impact factor: 24.633

Review 4.  Cellular reprogramming: a novel tool for investigating autism spectrum disorders.

Authors:  Kun-Yong Kim; Yong Wook Jung; Gareth J Sullivan; Leeyup Chung; In-Hyun Park
Journal:  Trends Mol Med       Date:  2012-07-06       Impact factor: 11.951

Review 5.  Direct somatic lineage conversion.

Authors:  Koji Tanabe; Daniel Haag; Marius Wernig
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

Review 6.  New approaches for direct conversion of patient fibroblasts into neural cells.

Authors:  Suhasni Gopalakrishnan; Pooja Hor; Justin K Ichida
Journal:  Brain Res       Date:  2015-10-16       Impact factor: 3.252

Review 7.  Direct lineage conversion of astrocytes to induced neural stem cells or neurons.

Authors:  Yanhua Huang; Sheng Tan
Journal:  Neurosci Bull       Date:  2015-04-08       Impact factor: 5.203

Review 8.  Induced neuronal reprogramming.

Authors:  Cheen Euong Ang; Marius Wernig
Journal:  J Comp Neurol       Date:  2014-05-21       Impact factor: 3.215

9.  Direct conversion of human fibroblasts into functional osteoblasts by defined factors.

Authors:  Kenta Yamamoto; Tsunao Kishida; Yoshiki Sato; Keisuke Nishioka; Akika Ejima; Hiroyoshi Fujiwara; Toshikazu Kubo; Toshiro Yamamoto; Narisato Kanamura; Osam Mazda
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

10.  Plant science. Fine-tuning photosynthesis.

Authors:  Jean-David Rochaix
Journal:  Science       Date:  2013-10-04       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.